![](/img/cover-not-exists.png)
Can we tailor neoadjuvant (primary) systemic therapy for breast cancer?
A. EniuVolume:
1
Language:
english
Pages:
5
DOI:
10.1007/s12254-008-0050-1
Date:
September, 2008
File:
PDF, 107 KB
english, 2008